Why DTIL? Precision BioSciences, Inc. Analysis, Price & AI Insights | Whystock
DTIL
$7.63+0.35 (+4.81%)
After Hours$7.63+0.00 (+0.00%)· Last close May 4
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States.